Prediction: This Will be Eli Lilly's Next Big Move.
Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...
Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In
We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...
Eli Lilly: A Strong Buy Amidst Obesity Treatment Market Dominance and Expanding Pipeline
In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Eli Lilly released a new form of its weight loss ... The company and its rival Novo Nordisk have both stepped in to address ...
Pharmaceutical Technology on MSN6d
Lilly’s EBGLYSS gains FDA approval for patients aged 12 and older
Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12 ...
Pharmaceutical Technology9d
Eli Lilly to invest $1.8bn in manufacturing capacity in Ireland
Lilly has announced a significant expansion of its manufacturing presence in Ireland, with a $1bn investment earmarked for ...
Healthline11d
Weekly Insulin Shots for Type 2 Diabetes May Be as Effective as Daily Shots
The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...
clinicaltrialsarena16d
Lilly’s efsitora shows promise in Phase III type 2 diabetes trials
Eli Lilly and Company has revealed positive topline results from the Phase III trials of efsitora alfa to treat adults with ...
Citi resumes coverage of Eli Lily with a Buy rating: Should you invest?
Discover Citi's bullish outlook on Eli Lilly with a $1,060 target. Is now the time to invest? Find key insights and price ...
AOL3d
Prediction: This Will be Eli Lilly's Next Big Move.
Eli Lilly (NYSE: LLY) offers investors the same ... By launching a split, Lilly could immediately address this problem, making it easier for a broader range of investors to buy shares.